Amended Statement of Beneficial Ownership (sc 13d/a)
30 June 2021 - 10:21PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE
13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
KINDRED
BIOSCIENCES INC.
(Name of Issuer)
Common Stock, par value $0.0001
(Title of Class of Securities)
494577109
(CUSIP Number of Class of Securities)
Alec N. Litowitz
Magnetar Capital LLC
1603 Orrington Ave.
Evanston, Illinois 60201
(847) 905-4400
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
June 28,
2020
(Date of Event which Requires Filing of this Statement)
If
the filing person has previously filed a Statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D
and is filing this Schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨
Note: Schedules filed in paper format shall include
a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7(b) for other parties to whom copies
are to be sent.
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. 494577109
|
SCHEDULE 13D
|
Page 2
of 10
|
|
|
1.
|
NAME
OF REPORTING PERSON:
Magnetar Financial LLC
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS
OO
|
5.
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
|
7.
|
SOLE
VOTING POWER
0
|
BENEFICIALLY
OWNED BY
|
8.
|
SHARED
VOTING POWER
3,421,425
|
EACH REPORTING
PERSON
|
9.
|
SOLE
DISPOSITIVE POWER
0
|
WITH
|
10.
|
SHARED
DISPOSITIVE POWER
3,421,425
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,421,425
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.55%
|
14.
|
TYPE
OF REPORTING PERSON
IA; OO
|
CUSIP No. 494577109
|
SCHEDULE 13D
|
Page 3 of 10
|
1.
|
NAME
OF REPORTING PERSON:
Magnetar Capital Partners LP
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS
OO
|
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
|
7.
|
SOLE
VOTING POWER
0
|
BENEFICIALLY
OWNED BY
|
8.
|
SHARED
VOTING POWER
3,421,425
|
EACH REPORTING
PERSON
|
9.
|
SOLE
DISPOSITIVE POWER
0
|
WITH
|
10.
|
SHARED
DISPOSITIVE POWER
3,421,425
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,421,425
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.55%
|
14.
|
TYPE
OF REPORTING PERSON
HC; OO
|
CUSIP No. 494577109
|
SCHEDULE 13D
|
Page 4 of 10
|
1.
|
NAME
OF REPORTING PERSON:
Supernova Management LLC
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS
OO
|
5.
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
|
7.
|
SOLE
VOTING POWER
0
|
BENEFICIALLY
OWNED BY
|
8.
|
SHARED
VOTING POWER
3,421,425
|
EACH REPORTING
PERSON
|
9.
|
SOLE
DISPOSITIVE POWER
0
|
WITH
|
10.
|
SHARED
DISPOSITIVE POWER
3,421,425
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,421,425
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.55%
|
14.
|
TYPE
OF REPORTING PERSON
HC; OO
|
CUSIP No. 494577109
|
SCHEDULE
13D
|
Page 5 of 10
|
|
1.
|
NAME
OF REPORTING PERSON:
Alec N. Litowitz
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) x
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS
OO
|
5.
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United States of America
|
NUMBER OF
SHARES
|
7.
|
SOLE
VOTING POWER
0
|
BENEFICIALLY
OWNED BY
|
8.
|
SHARED
VOTING POWER
3,421,425
|
EACH REPORTING
PERSON
|
9.
|
SOLE
DISPOSITIVE POWER
0
|
WITH
|
10.
|
SHARED
DISPOSITIVE POWER
3,421,425
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,421,425
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.55%
|
14.
|
TYPE
OF REPORTING PERSON
HC; IN
|
SCHEDULE
13D
This
Amendment No. 1 (the “Amendment”) relates to the Statement of Beneficial Ownership on Schedule 13D filed jointly by Magnetar
Financial LLC, a Delaware limited liability company (“Magnetar Financial”), Magnetar Capital Partners LP, a Delaware limited
partnership (“Magnetar Capital Partners”), Supernova Management LLC, a Delaware limited liability company (“Supernova
Management”), and Alec N. Litowitz (“Mr. Litowitz”) (collectively, the “Reporting Persons”) with the
SEC on June 25, 2021, (as amended by this Amendment, the “Schedule 13D”).
Except as set forth below,
all Items of the Schedule 13D remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to
such terms in the Schedule 13D.
|
Item 3.
|
source and amount of funds or other consideration
|
Item 3 of the Schedule 13D is hereby amended to add the following
information for updating:
The aggregate amount of funds used by the Reporting
Persons in purchasing the 479,842 Shares reported herein on behalf of the Funds have come directly from the assets of the Funds, which
may at any given time, have included margin loans made by brokerage firms in the ordinary course of business. The aggregate amount of
funds used by the Reporting Persons in purchasing the Shares on behalf of the Funds was $4,399,437.20 (excluding commissions and other
execution-related costs).
|
ITEM 4.
|
PURPOSE OF TRANSACTION
|
Item 4 of the Schedule 13D is hereby amended
to add the following information for updating:
Since the filing of the 13D
with the SEC on June 25, 2021, the Reporting Persons purchased 479,842 between June 25, 2021 and June 28, 2021 reported
herein which consists of (i) 271,278 Shares purchased for the benefit of PRA Master Fund, (ii) 151,109 Shares purchased for
the benefit of Constellation Fund; and (iii) 57,455 Shares purchased for the benefit of Systematic Master Fund
|
ITEM 5.
|
INTEREST IN SECURITIES OF THE ISSUER
|
Item 5 of the Schedule 13D is hereby amended
to add the following information for updating:
(a) As
of the close of business June 28, 2021, each of the Reporting Persons may have been deemed to have beneficial ownership of 3,421,425
Shares, which consisted of (i) 1,934,240 Shares held for the benefit of PRA Master Fund, (ii) 1,077,438 Shares held for the
benefit of Constellation Fund; and (iii) 409,747 Shares held for the benefit of Systematic Master Fund, and all such Shares represented
beneficial ownership of approximately 7.55% of the Shares.
(b) As
of the close of business June 28, 2021, each of the Reporting Persons may have been deemed to share the power to vote and direct
the disposition of 3,421,425 Shares, which consisted of (i) 1,934,240 Shares held for the benefit of PRA Master Fund, (ii) 1,077,438
Shares held for the benefit of Constellation Fund; and (iii) 409,747 Shares held for the benefit of Systematic Master Fund, and all
such Shares represented beneficial ownership of approximately 7.55% of the Shares.
(c) Except
as set forth on Schedule A attached hereto, the Funds had no transactions since the filing of the Schedule 13D on June 25,
2021 through the close of business on June 28, 2021, except for the transactions set forth on Schedule A. All of the transactions
set forth on Schedule A attached hereto were effected as part of the risk arbitrage strategy of Magnetar Financial for the accounts
of each of the Funds. The transactions in the Shares set forth on Schedule A were effected in open market transactions on NASDAQ
and various other trading markets.
SIGNATURE
After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
magnetar financial llc
|
|
|
|
By: Magnetar Capital Partners LP, its Sole Member
|
|
|
|
By:
|
/s/ Alec N. Litowitz
|
|
Name:
|
Alec N. Litowitz
|
|
Title:
|
Manager of Supernova Management LLC, the General Partner
of Magnetar Capital Partners LP
|
|
magnetar capital partners LP
|
|
|
|
By:
|
/s/ Alec N. Litowitz
|
|
Name:
|
Alec N. Litowitz
|
|
Title:
|
Manager of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP
|
|
supernova management llc
|
|
|
|
By:
|
/s/ Alec N. Litowitz
|
|
Name:
|
Alec N. Litowitz
|
|
Title:
|
Manager
|
|
|
|
/s/ Alec N. Litowitz
|
|
Alec N. Litowitz
|
|
|
|
|
SCHEDULE A
Funds
Date
|
Number of Shares Bought
|
Price Per Share($) (1)(2)
|
6/25/21
|
441,742
|
9.16842(3)
|
6/28/21
|
38,100
|
9.16955 (4)
|
(1)Excludes commissions and
other execution-related costs.
(2) Upon request by the staff of the Securities and
Exchange Commission, full information regarding the number of shares bought or sold (as the case may be) at each separate price will be
provided.
(3) Reflects a weighted average purchase price
of $9.16842per share, at prices ranging from $9.13 to $9.20 per share.
(4) Reflects a weighted average purchase price
of $9.16955 per share, at prices ranging from $9.15 to $9.20 per share.
Kindred Biosciences (NASDAQ:KIN)
Historical Stock Chart
From May 2024 to Jun 2024
Kindred Biosciences (NASDAQ:KIN)
Historical Stock Chart
From Jun 2023 to Jun 2024